Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:
Authors:
- Robert B MorelandRMRobert B Moreland
- Irwin GoldsteinIGIrwin Goldstein
- Noel N KimNKNoel N Kim
- Abdulmaged TraishATAbdulmaged Traish
Open Access
- 1 April 1999
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 10 (3) , 97-104
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Molecular Cloning and Expression of Human cGMP-Binding cGMP-Specific Phosphodiesterase (PDE5)Biochemical and Biophysical Research Communications, 1998
- THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE (PDE) INHIBITORS ON HUMAN AND RABBIT CAVERNOUS TISSUE IN VITRO AND IN VIVOJournal of Urology, 1998
- Hydropathic Analysis and Mutagenesis of the Catalytic Domain of the cGMP-Binding cGMP-Specific Phosphodiesterase (PDE5). cGMP versus cAMP Substrate SelectivityBiochemistry, 1998
- Cyclic GMP Causes Ca2+ Desensitization in Vascular Smooth Muscle by Activating the Myosin Light Chain PhosphataseJournal of Biological Chemistry, 1997
- Cyclic nucleotide phosphodiesterase in human cavernous smooth muscleWorld Journal of Urology, 1997
- Signal transduction in cavernous smooth muscleWorld Journal of Urology, 1997
- Mechanisms of Venous Leakage: A Prospective Clinicopathological Correlation of Corporeal Function and StructureJournal of Urology, 1996
- Identification of Key Amino Acids in a Conserved cGMP-binding Site of cGMP-binding PhosphodiesterasesJournal of Biological Chemistry, 1996
- The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterasesMolecular and Cellular Biochemistry, 1993
- Regulation of contraction and relaxation in arterial smooth muscle.Hypertension, 1992